| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/15/2009 | EP2046385A2 Composition for modulating the expression of cell adhesion molecules |
| 04/15/2009 | EP2046331A1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 04/15/2009 | EP2046323A2 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 04/15/2009 | EP2046305A2 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids |
| 04/15/2009 | EP2003130A9 Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/15/2009 | EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| 04/15/2009 | EP1690549B1 Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals |
| 04/15/2009 | EP1680099B1 Hdl-boosting combination therapy complexes |
| 04/15/2009 | EP1480678B1 Treatment of ophthalmic disorders using urea and urea derivatives |
| 04/15/2009 | EP1458677B1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/15/2009 | EP1419143B1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 04/15/2009 | EP1406599B1 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of healthy skin |
| 04/15/2009 | EP1373506B1 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1333880B1 Transdermal drug delivery devices having coated microprotrusions |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1258251B1 Compositions for preventing and treating digestive diseases |
| 04/15/2009 | EP1003474B1 Method of treating dry eye disease with purinergic receptor agonists |
| 04/15/2009 | EP0792292B2 Estrogen receptor |
| 04/15/2009 | CN101410414A Synergistic compositions for treating HIV-1 |
| 04/15/2009 | CN101410140A Engineered antibody-stress protein fusions |
| 04/15/2009 | CN101410139A Use of the staudinger ligation in in vivo assembly of a biologically active compound |
| 04/15/2009 | CN101410132A GDF-9/BMP-15 modulators for the treatment of bone disorders |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/15/2009 | CN101406703A Transdermal analgesic systems with reduced abuse potential |
| 04/15/2009 | CN101406465A Combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 04/15/2009 | CN101406454A Low molecular weight chitosan modified liposomes and preparation method thereof |
| 04/15/2009 | CN100478689C Polypeptide and use thereof |
| 04/15/2009 | CN100478636C Mounting arrangement for auxiliary burner or lance |
| 04/15/2009 | CN100478031C The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 04/15/2009 | CN100478030C SARS resisting medicine action target and its preventing and treating medicine |
| 04/15/2009 | CN100477995C Fortifier |
| 04/15/2009 | CN100477986C Ascending-dose dosage form |
| 04/14/2009 | US7517992 (-)-cis-1-(5-(4-fluorophenoxy)-pyridin-2-yl)-3-(4,7-difluoro-1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea; improved resistance and pharmacokinetic profile; polymerase inhibitors; potent against virus comprising drug escape mutations |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517962 TWEAK receptor |
| 04/14/2009 | US7517904 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/14/2009 | US7517887 Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517672 Nucleic acids encoding mammalian T-type calcium channels |
| 04/14/2009 | US7517669 Increasing the intracellular amount of at least one ferritin-H or a derivative to an effective level for suppressing disease caused or enhanced by effects of intracellular iron mismanagement |
| 04/14/2009 | US7517666 Using urease as tool in identifying modulators of bacterial propagation; enzyme inhibitors |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517540 Cranberry seed oil extract and compositions containing components thereof |
| 04/14/2009 | US7517535 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 04/14/2009 | US7517526 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 04/14/2009 | US7517525 Methods of inhibiting amyloid toxicity |
| 04/14/2009 | CA2396865C Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/14/2009 | CA2395016C Treatment of dna viral infections |
| 04/14/2009 | CA2389111C Novel combination of loteprednol and .beta.2-adrenoceptor agonists |
| 04/14/2009 | CA2387844C Treatment of emphysema using rar selective retinoid antagonists |
| 04/14/2009 | CA2362914C Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 04/14/2009 | CA2329004C Combination of insulin sensitizer with anorectic for treating or preventing diabetes |
| 04/14/2009 | CA2269682C Improved pharmaceutical compositions |
| 04/14/2009 | CA2240256C Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 04/14/2009 | CA2237582C Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 04/14/2009 | CA2232378C Aerosol compositions |
| 04/14/2009 | CA2231244C Anti-stress agents for aquatic animals |
| 04/14/2009 | CA2139757C Liposomes, method of preparing the same and use thereof in the preparation of drugs |
| 04/09/2009 | WO2009045796A1 Pharmaceutical combination of aliskiren and valsartan |
| 04/09/2009 | WO2009044774A1 Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient |
| 04/09/2009 | WO2009044548A1 Antidiarrhetic composition, product containing the same and method of preventing diarrhea |
| 04/09/2009 | WO2009043959A1 Method for identifying patients with sporadic burkitt's lymphoma, identification method and use of compounds for the treatment of sporadic burkitt's lymphoma |
| 04/09/2009 | WO2009043902A1 Bisbenzimidazoles as antimalarial agents |
| 04/09/2009 | WO2009043834A1 Pharmaceutical compositions of 5-hydr0xytrypt0phan and serotonin-enhancing compound |
| 04/09/2009 | WO2009043170A1 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 04/09/2009 | WO2009023845A3 Combination therapy with synthetic triterpenoids and gemcitabine |
| 04/09/2009 | WO2008137126A3 Combination therapy for the treatment of hcv infection |
| 04/09/2009 | WO2006060790A3 Neoadjuvant genetic compositions and methods |
| 04/09/2009 | WO2005041865A3 Compounds and method for treating cancer |
| 04/09/2009 | WO2004100896A3 Anti-aging nutritional supplement |
| 04/09/2009 | WO2002026020A9 Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics |
| 04/09/2009 | US20090093639 Prodrugs of carbamate inhibitors of IMPDH |
| 04/09/2009 | US20090093549 Aqueous Pharmaceutical Compositions Of 2,6-Diisopropylphenol (Propofol) And Their Uses |
| 04/09/2009 | US20090093546 Method and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using RXR Modulators |
| 04/09/2009 | US20090093503 Combinations comprising antimuscarinic agents and pde4 inhibitors |
| 04/09/2009 | US20090093487 Compositions for topical application having androgenic actions |
| 04/09/2009 | US20090093413 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/09/2009 | US20090093412 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/09/2009 | US20090093000 Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease |
| 04/09/2009 | US20090092963 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
| 04/09/2009 | US20090092693 Platelet manipulation to prevent and treat endovascular disease and its sequelae, to prevent and treat arrhythmias and to prevent malignancy |
| 04/09/2009 | US20090092684 Small molecule antagonists of bcl-2 family proteins |
| 04/09/2009 | US20090092660 Methods and compositions for needleless delivery of particles |
| 04/09/2009 | US20090092613 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 04/09/2009 | US20090092600 Methods and compositions relating to the regulation of muc1 by hsf1 and stat3 |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |
| 04/09/2009 | US20090092585 Treating diarrhea in dogs |
| 04/09/2009 | US20090092546 Carrier molecules |
| 04/09/2009 | CA2739523A1 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 04/09/2009 | CA2701155A1 Therapeutic agents for graft-versus-host disease comprising interleukin 6 receptor inhibitor as active ingredient |
| 04/09/2009 | CA2701009A1 Electricity-generating particulates and the use thereof |
| 04/09/2009 | CA2698330A1 Galenical formulations of organic compounds |
| 04/09/2009 | CA2697437A1 Pharmaceutical combination of aliskiren and valsartan |
| 04/08/2009 | EP2045241A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists |
| 04/08/2009 | EP2044958A2 Pharmaceutical composition for treating arteriosclerosis |
| 04/08/2009 | EP2044957A1 Treatment agent for inflammatory bowel disease |
| 04/08/2009 | EP2044956A1 Hematopoietic stem cell proliferation promoter |
| 04/08/2009 | EP2044955A2 Methods for detecting and inhibiting angiogenesis |